|
 |
European Pharmaceutical Contractor
|
EPC has a new owner and this is the first edition of any of our three magazines - EPC, EBR and PMPS - that has been produced entirely under the new management of Samedan Ltd. As we go forward into 2002 we confidently believe that all three magazines will go from strength to strength and build on the quality that our readers have come to expect. It is also EPC's fifth anniversary and our 21st issue, with over 400 editorial articles behind us covering an extraordinary range of topics. It is not surprising then that we return to themes that may be familiar to some of our regular readers. But this only emphasises their importance and general interest.
One of these important themes is that of the role of 'electronics' in clinical development. In this issue we have six articles that address this theme. Over the years we have seen a number of articles that have emphasised the promise of electronics in making a major contribution to the speeding up of clinical trials. These articles reinforce the promise, but a promise it remains, and it will be, in my opinion, several years before electronic trials replace the more traditional, albeit slower, methodology. In a related article, Clarke Graham's article on brand protection discusses how the Internet can be both a benefit and a threat by providing global branding reach.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
